NCT01521845View on ClinicalTrials.gov

Study of the Effect of omega3 on Biomarkers of Cardiac Necrosis (CKMB and Troponin I) and Inflammation Marker (CRP) After Elective Percutaneous Coronary Intervention (PCI)

PHASE3CompletedINTERVENTIONAL
Enrollment

104

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

May 31, 2012

Study Completion Date

May 31, 2012

Conditions
Coronary Arteriosclerosis
Interventions
DRUG

omega 3

3 gram omega 3 (400mg EPA and 200mg DHA) 12hours before PCI

Trial Locations (1)

Unknown

Moddaress Hospital, Tehran

All Listed Sponsors
lead

Shahid Beheshti University of Medical Sciences

OTHER

NCT01521845 - Study of the Effect of omega3 on Biomarkers of Cardiac Necrosis (CKMB and Troponin I) and Inflammation Marker (CRP) After Elective Percutaneous Coronary Intervention (PCI) | Biotech Hunter | Biotech Hunter